title: National survey of ethical issues presented to drug information centers.
abstract: Whether and how drug information centers respond to calls from the public that involve ethical issues was studied. A survey describing six ethical dilemmas typical of those presented by calls from the public was mailed to pharmacists in 154 drug information centers to see how the questions would be handled. Centers that had written policies governing responses to questions with ethical implications were asked to submit those policies. One hundred twenty-six centers (82%) responded to the survey; of these, 81 (64.3%) answered questions from the public. There were no significant differences in characteristics between centers that did and did not respond to public calls. The case analyses, completed only by pharmacists in centers that responded to public calls, covered such issues as invasion of privacy, social responsibility, personal liability, and interference with the patient-physician relationship. Respondents exercised a wide degree of discretion in determining if they would answer a question; for example, while only 4% would not answer a question concerning the efficacy of a weight-loss diet patch, 77% reported they would not respond to a caller asking for information on drugs that could interfere with the results of a polygraph test. Although respondents often cited institutional policy as the reason for failing to respond to a question, none submitted a copy of such a policy. The pharmacists' responses indicated a high degree of moral and social sensitivity; nonetheless, written policies should be developed to assist drug information center staff members in handling questions that have ethical implications.
authors.affiliation: Pharmacy and Drug Information Service, Hamot Medical Center, Erie, PA 16550.
authors.forename: W N
authors.initials: WN
authors.lastname: Kelly
authors.forename: E C
authors.initials: EC
authors.lastname: Krause
authors.forename: W J
authors.initials: WJ
authors.lastname: Krowinski
authors.forename: T R
authors.initials: TR
authors.lastname: Small
authors.forename: J F
authors.initials: JF
authors.lastname: Drane
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000328:Adult; D000529:Complementary Therapies; D028661:Complicity; D004346:Drug Information Services / Q000458:organization & administration* / Q000592:standards; D004512:Education, Pharmacy; D004994:Ethics, Pharmacy; D005260:Female; D006801:Humans; D013287:Illicit Drugs; D033181:Information Dissemination; D008297:Male; D008385:Marijuana Smoking / Q000652:urine; D035863:Moral Development; D028681:Moral Obligations; D010595:Pharmacists; D037841:Pregnant People; D018570:Risk Assessment; D012945:Social Values; D011795:Surveys and Questionnaires; D013723:Teratogens; D014481:United States
chemical_list: D000319:Adrenergic beta-Antagonists; D013287:Illicit Drugs; D013723:Teratogens